
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ISOVUE-M 200 | Bracco Diagnostics | N-018735 RX | 1985-12-31 | 1 products, RLD, RS |
| ISOVUE-300 | Bracco Diagnostics | N-018735 RX | 1985-12-31 | 1 products, RLD, RS |
| ISOVUE-370 | Bracco Diagnostics | N-018735 RX | 1985-12-31 | 1 products, RLD, RS |
| ISOVUE-M 300 | Bracco Diagnostics | N-018735 RX | 1985-12-31 | 1 products, RLD, RS |
| ISOVUE-200 | Bracco Diagnostics | N-018735 RX | 1987-07-07 | 1 products, RLD, RS |
| ISOVUE-250 | Bracco Diagnostics | N-018735 RX | 1992-07-06 | 1 products, RLD, RS |
| ISOVUE-300 | Bracco Diagnostics | N-020327 RX | 1994-10-12 | 1 products, RLD, RS |
| ISOVUE-370 | Bracco Diagnostics | N-020327 RX | 1994-10-12 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
|---|---|---|
| iopamidol | ANDA | 2025-07-17 |
| isovue | New Drug Application | 2024-12-20 |
| isovue-m | New Drug Application | 2022-11-03 |
| isovue-m 200 | New Drug Application | 2017-01-17 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Coronary stenosis | D023921 | EFO_1000882 | — | — | — | — | 3 | — | 3 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | 2 | 1 | 3 |
| Arterial occlusive diseases | D001157 | EFO_0009085 | — | — | — | — | 2 | — | 2 |
| Chronic renal insufficiency | D051436 | — | N18 | — | — | — | 1 | 1 | 2 |
| Hypothyroidism | D007037 | EFO_0004705 | E03.9 | — | — | — | 1 | — | 1 |
| Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | — | 1 | — | 1 |
| Renal insufficiency | D051437 | — | N19 | — | — | — | 1 | — | 1 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | — | 1 | — | 1 |
| Pulmonary embolism | D011655 | EFO_0003827 | I26 | — | — | — | 1 | — | 1 |
| Embolism | D004617 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Coronary artery disease | D003324 | — | I25.1 | — | 1 | — | — | — | 1 |
| Drug common name | Iopamidol |
| INN | iopamidol |
| Description | Iopamidol is a benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a (2S)-2-hydroxypropanamido group at the 5-position. It has a role as a radioopaque medium, an environmental contaminant and a xenobiotic. It is a benzenedicarboxamide, an organoiodine compound and a pentol. |
| Classification | Small molecule |
| Drug class | iodine-containing contrast media |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I |
| PDB | — |
| CAS-ID | 60166-93-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1200932 |
| ChEBI ID | 31711 |
| PubChem CID | 65492 |
| DrugBank | DB08947 |
| UNII ID | JR13W81H44 (ChemIDplus, GSRS) |

